Multiple Sclerosis Resource Centre
  • Home
  • MSRC Grand Opening 30/05/12
  • About MS
  • MSRC Services
  • Get Involved
  • MS Research News
  • MSRC Groups
  • Useful Resources
  • Welcome To Josephs Court, MS Centre Of Excellence
  • Advertising
  • Best Bet Diet Group
  • E-Newsletter
  • Contact Us
  • Investor in People
    You are here : Home » MS Research News » Drugs » Aimspro (Goats Serum) » Aimspro - Published Research Papers

    Aimspro - Published Research Papers

    A A A
    [Print this page]

    Share |

    Goat serum product 'Aimspro' restores conduction in demylienated human optic nerve fibres


    Acute optic neuritis is a common manifestation of multiple sclerosis. It presents as an episode of monocular blurring of central vision, with a pronounced effect on colour discrimination. While spontaneous resolution usually follows, successive attacks may result in irreversible and often, slowly progressive, visual loss. No medication has yet been available to improve visual function in these chronically affected patients. Here we present evidence of a promising approach to therapy along with electrophysiological indications of a remarkable rapidity of onset.

    For the full paper from the Journal of Clinical Neuroscience click here

    © Multiple Sclerosis Resource Centre

    Related Items
    Aimspro - Oxford Optic Neuritis Trial
    Aimspro Latest News

    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.